In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
In recent investment activity, Julie Johnson, the congressional representative for Texas's 32nd district, has made several stock transactions in her Merrill Lynch Tax Efficient Core, Merrill Lynch ...
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...
The Pantera icon loved digging into his Riffer Madness “Feedback Sack” and answering readers’ questions. Here he offers gear ...
Data center developer ImpactData has partnered with Raeden for its debut data center in North Carolina. Raeden signed a joint ...
The data cutoff date for the current analysis of the study was August 8, 2024. With 29.1 months of median follow-up, 12% of ...
Campbell Hall makes a third-quarter comeback and will next play Crespi on Friday; plus other scores from Wednesday’s first ...
For The Win on MSN16d
The Nets' 6 points in 6 seconds helped a bettor win $26K in the most unlikely wayThey did it by letting Brooklyn's Keon Johnson nail what should've been a meaningless 3-pointer ... A New York bettor won $26,667.25 on a 4-leg $500 ML parlay yesterday 🤑 Nets ML (+345) ...
Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that it costs $100 to $300 million to develop a biosimilar and that it takes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback